This page lists the SEC filings reported by Baupost Group.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2020-11-04 | BAUPOST GROUP LLC/MA | Garrett Motion Inc. | 3,575,000 | 4.7% | EDGAR |
| SC 13D | 2020-10-23 | BAUPOST GROUP LLC/MA | Garrett Motion Inc. | 3,575,000 | 4.7% | EDGAR |
| SC 13G/A | 2020-10-09 | BAUPOST GROUP LLC/MA | Akebia Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2020-08-10 | BAUPOST GROUP LLC/MA | Translate Bio, Inc. | 18,044,239 | 24.3% | EDGAR |
| SC 13D/A | 2020-07-27 | BAUPOST GROUP LLC/MA | VIASAT INC | 16,288,959 | 24.1% | EDGAR |
| SC 13D/A | 2020-05-11 | BAUPOST GROUP LLC/MA | Translate Bio, Inc. | 17,544,239 | 27.9% | EDGAR |
| SC 13G/A | 2020-04-09 | BAUPOST GROUP LLC/MA | Akebia Therapeutics, Inc. | 17,527,968 | 13.5% | EDGAR |
| SC 13G/A | 2020-02-13 | BAUPOST GROUP LLC/MA | ANTERO RESOURCES Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-13 | BAUPOST GROUP LLC/MA | Akebia Therapeutics, Inc. | 19,571,453 | 16.4% | EDGAR |
| SC 13G/A | 2020-02-13 | BAUPOST GROUP LLC/MA | Atara Biotherapeutics, Inc. | 8,308,900 | 15.3% | EDGAR |
| SC 13G/A | 2020-02-13 | BAUPOST GROUP LLC/MA | Univar Solutions Inc. | 11,025,000 | 6.5% | EDGAR |
| SC 13G/A | 2020-02-13 | BAUPOST GROUP LLC/MA | Trilogy Metals Inc. | 12,182,568 | 8.7% | EDGAR |
| SC 13G/A | 2020-02-13 | BAUPOST GROUP LLC/MA | Qorvo, Inc. | 2,750,000 | 2.4% | EDGAR |
| SC 13G/A | 2020-02-13 | BAUPOST GROUP LLC/MA | Nexeo Solutions, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2020-02-13 | BAUPOST GROUP LLC/MA | Vista Oil & Gas, S.A.B. de C.V. | 8,333,331 | 9.4% | EDGAR |
| SC 13G/A | 2019-12-09 | BAUPOST GROUP LLC/MA | Paratek Pharmaceuticals, Inc. | 1,552,286 | 4.7% | EDGAR |
| SC 13D | 2019-09-20 | BAUPOST GROUP LLC/MA | Translate Bio, Inc. | 17,544,239 | 29.2% | EDGAR |
| SC 13G/A | 2019-09-09 | BAUPOST GROUP LLC/MA | Translate Bio, Inc. | 12,272,502 | 24.1% | EDGAR |
| SC 13G/A | 2019-07-09 | BAUPOST GROUP LLC/MA | Cheniere Energy, Inc. | 10,674,135 | 4.2% | EDGAR |
| SC 13D/A | 2019-06-04 | BAUPOST GROUP LLC/MA | Orexigen Therapeutics, Inc. | 0 | 0.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.